Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Yes Bank confident of...

    Yes Bank confident of Fortis Healthcare fetching good valuation

    Written by Ruby Khatun Khatun Published On 2018-04-30T10:30:57+05:30  |  Updated On 30 April 2018 10:30 AM IST
    Yes Bank confident of Fortis Healthcare fetching good valuation

    Mumbai: Terming Fortis Healthcare, which is on the block, as “a very attractive asset”, its single largest shareholder Yes Bank exuded the confidence of a sound resolution with a good valuation and thus help drive out of the management crisis plaguing one of the largest hospital chains in the county.


    In February this year, Yes Bank, which was the largest lender to the hospital, had acquired a 17.31% stake by invoking nearly 9 crores pledged shares. Later in mid-March, it sold 2.17% of this bringing down its shareholding to 15.14% as of March 2018. Still, this makes the private lender the single largest shareholder in the New Delhi based hospital chain.


    “Fortis is more than a performing asset for us,” Yes Bank managing director and chief executive Rana Kapoor said, adding, “I am very convinced that there will be a very good resolution.”


    In the March quarter earnings announcement, the bank has last week said its over Rs1,500 crore exposure to Fortis is classified as “standard” in its books and that the bank has sufficient securities to cover the exposure.


    Kapoor said he is not concerned about the quality of the bidders as Fortis is a prime healthcare asset in the country.


    Four entities—the Manipal/TPG consortium, the KKR- backed Radiant Life Care, Malaysian major IHH Healthcare, and the family offices of the Munjals and Burmans — have given binding offers to the Fortis board.


    “There are four-five world class bidders and the asset will be valued properly in the course of time,” Kapoor told reporters on the sidelines of an economic summit at the BSE.


    He said the bank, as a shareholder, is not active in the valuation process of the hospital chain but has observed improvement in transparency and disclosures in the process.


    “At the end of the day, it is going to be very competitive and fetch fantastic value for all investors, including minority shareholders,” he added.


    On April 25, Renuka Ramnath, former head of ICICI Venture, resigned from the expert committee formed to evaluate the binding bids.

    confidentfetchingFortisFortis Healthcaregood valuationhospital chainsIHH HealthcareManipalMunjalsRadiant Life CareRana KapoorTPGYes Bank
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok